# Kaub et al. 2026 — First QDM Imaging of Single-Domain Magnetite in Human Brain Tissue **Cite**: K. A. U. Kaub, N. S. B. Gysi, A. R. K. Breitwieser, B. A. Maher, A. T. Kuan, S. Milz, C. Schmitz et al. *RSC Advances* **16**, 983–994 (2026). DOI: [10.1039/D5RA08546B](https://pubs.rsc.org/en/content/articlelanding/2026/RA/D5RA08546B). Open Access. Data: [Zenodo 14958851](https://doi.org/10.5281/zenodo.14958851). **Why this is in the course**: First image-level evidence, at single-particle spatial precision, of magnetite nanoparticles inside post-mortem human brain tissue — taken with a quantum diamond microscope (QDM). Bridges the airborne-pollution magnetite neurotoxicology line (Maher, Calderón-Garcidueñas) to direct, falsifiable tissue measurement. Co-author **Barbara Maher** is the lead voice on airborne magnetite as a probable neurotoxicant. The instrument (QDM, NV-center diamond) is a peer-reviewed, working magnetometer with sub-50 nm sensitivity and mm-scale field of view. --- ## 1. The instrument — Quantum Diamond Microscope (QDM) - **What it is**: Wide-field magnetic imager using a thin NV-center (nitrogen-vacancy) diamond layer as the sensor. Optically detected magnetic resonance (ODMR) of the NV electronic spin reads out local magnetic field strength at each pixel. - **Sensitivity floor in this study**: ~50 nm single-domain magnetite (single-particle detection limit). High-sensitivity mode with ~35 min integration per iteration × 6–22 iterations, stacked and averaged. - **Field of view**: 1920 × 1200 px = 2.25 × 1.40 mm². ~10⁶× larger area than typical TEM section. - **Bias field**: 0.9 mT DC, repeatedly reversed → maps represent remanent magnetization at near-zero net field. - **Modes used**: high-sensitivity (human + rat brain) and projective magnetic microscopy (PMM, magnetotactic bacteria control). The point of quoting all this in a course: QDM is a *real, peer-reviewed, working* magnetometer at the relevant scale. Not a proposed instrument, not a simulation. It's the kind of tool that turns "are there magnetic nanoparticles in this tissue?" from a contested claim into a measurement. ## 2. The contamination-control move (the part that matters for Brasovan-style skepticism) The authors collect each magnetic map **twice** with a slight offset. A signal that appears in both maps at the same physical location is *bona fide*. A signal that appears in only one map is artifact (surface contamination, scratches, sample motion, diamond sensor noise). > "The duplicate, high-sensitivity magnetic microscopy images from the QDM allowed us to identify magnetite nanoparticles in brain tissue." This is a falsifiability move baked into the protocol. It is exactly the pattern that the Anthrocybernetics course wants students to recognize: a measurement instrument with built-in null control. Use it in the course as a worked example of *real instrument, real contamination rejection, real null*. Practical contamination steps they layered on top: - PTFE filtration (50 nm) of all viscous chemicals; 0.2 µm for the rest. - 10% HCl wash of glassware + filtered distilled water rinse. - Alumina polish (1 µm) of the sample surface for ≥1 min, ultrasonic Milli-Q rinse, isopropanol wipe. - 1.5 T pulse field (in-plane, 0° declination/inclination) applied to each sample to align contaminating moments and subtract them. Scratches (Fig. 2) trap contaminants and produce dipolar signals — pre-polish vs. post-polish comparison shows the dipoles disappearing with the scratches. This is the kind of careful negative-control reporting that gives the positive claim weight. ## 3. What they actually found ### Human brain tissue (4 brain-stem samples, University of Rostock autopsy, ethical approval A 2021-0282) Four bona-fide dipolar sources in three samples: - **Red nucleus** (mesencephalon) - **Substantia nigra pars compacta** (mesencephalon) - **Inferior olivary nucleus** (medulla oblongata) Particle sizes (from dipole fits): **60–135 nm**, consistent with the larger tail of TEM size distributions for brain magnetite. Most brain magnetite is <50 nm (below QDM detection) — QDM is imaging the rarer larger particles. **Magnetization directions clustered in the northern hemisphere** (not random). Random orientation would be expected for biogenic magnetite (produced in vivo by magnetosome-like processes or as a metabolic byproduct). The northern-hemisphere clustering suggests **non-biogenic, externally acquired magnetite** — i.e., particles that did not form in the tissue but were deposited there. This is the airborne-magnetite neurotoxicology hypothesis at single-particle spatial precision. All four particles were in small local nerve fibers, not in neuron perikarya. The authors flag this as weak evidence *against* a physiological magnetoreception function for brain magnetite (those particles should sit in neuronal cell bodies). They are appropriately cautious — four particles is not enough to rule anything in or out. But it's the first image-level data point on location. ### Rat cerebral cortex (4 samples, UC Davis, vivarium adjacent to heavily trafficked tunnel) - Three rats exposed to unfiltered traffic air; one to filtered air. - 14 map pairs collected. Four discarded for high blank-epoxy signal counts (surface contamination). One sample excluded for apparent sample-motion smearing (signatures clustered at antipodal declinations ~120°/~300°, characteristic of motion-blur). - Of the remaining, multiple bona-fide signals in tissue. One strong signal in rat cortex had a particle size above 300 nm — interpreted as a cluster of smaller particles. ### Magnetotactic bacteria (control) Enriched MTB from a freshwater pond in Bavaria — same QDM workflow in PMM mode, single iteration. Confirms the instrument can image biogenic magnetite chains and provides a positive control for the tissue imaging. ## 4. Why this is a load-bearing source for the Anthrocybernetics course ### 4.1 Bridges airborne-magnetite neurotoxicology to tissue imaging The Calderón-Garcidueñas / Maher line has argued for ~15 years that airborne magnetite nanoparticles (from combustion, traffic, industry) cross the olfactory mucosa, bypass the blood-brain barrier, accumulate in the brainstem, and are associated with neurodegenerative pathology (Alzheimer's, Parkinson's, ALS-like presentation, "quadruple abnormal protein aggregates"). The evidence until now has been: - TEM identification of magnetite in brain tissue (plaque cores, brainstem). - Magnetic measurements on bulk tissue (SQUID, Mossbauer, hysteresis). - Environmental monitoring of airborne PM. - Epidemiological correlations. What's been missing is *where in the tissue* the particles sit, at single-particle spatial precision, with confidence the signal isn't contamination. This paper provides exactly that, for the first time, in post-mortem human brainstem. ### 4.2 Couples to the URF "Biological Ramsauer-Townsend Gate" framing The Unified Resonance Framework (URF) treats Fe-57 (14.4 keV Mössbauer, spin-1/2, chiral) as a candidate Einstein-Rosen-bridge throat in biological matter. The same iron-oxide chemistry that is the candidate spin-1/2 chirality bridge is the very material being imaged here. QDM imaging of magnetite in tissue is a direct experimental handle on the URF Fe-oxide anchor — we can now say "the iron we theorize about is *here*, in this tissue, at this scale." ### 4.3 Couples to DARPA-PS-26-10 Generative Optogenetics (read/write on biological magnetite) DARPA-PS-26-10 (GO / NAC, BTO Dec 19 2025) is the *write* side: build a protein complex that transduces light into DNA/RNA sequence in living cells. Kaub 2026 is the *read* side: image magnetic nanoparticles in tissue non-destructively. Together they begin to sketch a real read/write toolkit on biological magnetite and iron biology. ### 4.4 Empirical backbone for "weak-field × structured matter" synthesis (pulse 48) The pulse-48 synthesis abstract argues for a single frequency-tuning of weak field × structured matter physics across scales (14.4 keV nuclear, 7.83 Hz biological, 34 GHz A-DNA antenna, MPD plasma containment). Magnetite in human brain tissue is now a documented, single-particle-scale endpoint. It is not a hypothesis or an extrapolation — it is a measurement. ### 4.5 Gives the NWI EMF pilot a real biological endpoint The Hammond, IN infrasound field experiment and the NWI EMF pilot at Purdue Research Park are behavioral / exposure-response designs. The QDM protocol gives them a candidate *biological endpoint*: magnetite nanoparticle load and localization in exposed vs. control rat brain tissue. If the pilot finds a behavioral effect, the next step is to ask "did the magnetite load change?" That is now a tractable measurement. ### 4.6 Survives the Brasovan / "is it real?" test QDM imaging is: - peer-reviewed (RSC Advances, Royal Society of Chemistry) - open access (CC-BY 3.0) - methodologically conservative (high-sensitivity ODMR is a 20-year-old technique) - instrumented (no exotic physics) - null-controlled (duplicate-map protocol) - contamination-aware (multiple orthogonal cleanup steps) - data-published (Zenodo, raw maps available) Nothing in this paper requires commitment to any speculative layer of the ghojualamanchu framework. It is a clean experimental result with clean negative controls. It carries weight without requiring belief in the unified field picture. ## 5. Limitations the paper itself flags - **Four particles is not many.** The authors are explicit that this is a *tentative* conclusion about non-biogenic origin. The northern-hemisphere clustering is suggestive, not decisive. - **50 nm detection limit.** Most brain magnetite is below this. The paper images the rarer large tail. - **Post-mortem formalin-fixed tissue.** Magnetite can transform during fixation (oxidation state changes). The van der Weerd et al. 2020 *Sci. Rep.* paper (ref 9) is cited for this caveat. - **No causation.** Imaging magnetite in tissue does not establish that it caused any pathology. Association, not mechanism. - **One human cohort.** Rostock, Germany — environmental exposure profile specific to that region. ## 6. Course-pedagogical moves - **Lecture hook**: "We can see individual 60-nm magnetite particles in a human brainstem with a quantum sensor the size of a postage stamp. Here is how." - **Methodology case study**: duplicate-map contamination rejection. Use it as the canonical example of "real instrument, real null, real falsifiability." - **Cross-scale synthesis**: anchor the Fe-oxide chemistry thread. Connect to URF (Fe-57 Mössbauer), to DARPA GO (read/write on biological Fe), to NWI EMF pilot (candidate biological endpoint). - **Critical reading exercise**: have students identify the four sources of magnetite signal in this paper (real tissue magnetite, surface contamination, polishing residue, MTB control) and the protocol step that distinguishes each. - **Open question for course**: Is there a clean dose-response between airborne PM₂.₅ magnetite and brainstem magnetite load in animal models? If yes, this paper's "first image" claim becomes the anchor of a much larger story. ## 7. Citation form for course materials > Kaub, K. A. U. et al. First imaging of individual single-domain magnetite particles in human brain tissue with the quantum diamond microscope. *RSC Adv.* **16**, 983–994 (2026). DOI: 10.1039/D5RA08546B. ## 8. Source ledger entry Logged to `ghojualamanchu/memory/sources.md` under "Magnetite in Brain / Air Pollution Neurotoxicology" — Pulse 54, 2026-06-19.